We present evidence that bacterial spores engineered to express SARS-CoV-2 antigens and delivered as an intranasal boost following a systemic prime (either a S protein subunit or the AZD1222 COVID-19 vaccine) induce antigen-specific sIgA. The gene discussed is PROS1; the disease is COVID-19.